Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia von Nij Bijvank, J.A, van Rijn, L.J, Balk, L.J, Tan, H.S, Uitdehaag, B.M.J, Petzold, A

Volltext

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanne... von Weeda, M.M., Middelkoop, S.M., Steenwijk, M.D., Daams, M., Amiri, H., Brouwer, I., Killestein, J., Uitdehaag, B.M.J., Dekker, I., Lukas, C., Bellenberg, B., Barkhof, F., Pouwels, P.J.W., Vrenken, H.

Volltext

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network von Nij Bijvank, J.A., Strijbis, E.M.M., Nauta, I.M., Kulik, S.D., Balk, L.J., Stam, C.J., Hillebrand, A., Geurts, J.J.G., Uitdehaag, B.M.J., van Rijn, L.J., Petzold, A., Schoonheim, M.M.

Volltext

High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate von Doesburg, D., Vennegoor, A., Uitdehaag, B.M.J., van Oosten, B.W.

Volltext

The natural disease course of Vanishing White Matter von van der Knaap, M.S, Hamilton, E.M.C, van der Lei, H.D.W, Gemke, R.J.B.J, Uitdehaag, B.M.J, de Vet, R, Witte, B.I

Volltext

P.0128 Increased dynamic functional network reconfiguration in cognitively declining multiple sclerosis patients von Broeders, T., Douw, L., Eijlers, A.J.C., Dekker, I., Uitdehaag, B.M.J., Barkhof, F., Hulst, H.E., Vinkers, C.H., Geurts, J.J.G., Schoonheim, M.M.

Volltext

Inter-observer variability of the EEG diagnosis of seizures in comatose patients von Ronner, H.E, Ponten, S.C, Stam, C.J, Uitdehaag, B.M.J

Volltext

Gender differences in multiple sclerosis: Cytokines and vitamin D von Eikelenboom, M.J, Killestein, J, Kragt, J.J, Uitdehaag, B.M.J, Polman, C.H

Volltext

Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS von van Winsen, L.M.L, Hooper-van Veen, T, van Rossum, E.F.C, Koper, J.W, Barkhof, F, Polman, C.H, Uitdehaag, B.M.J

Volltext

P15.04DEVELOPMENT OF A NEW QUESTIONNAIRE TO MEASURE INSTRUMENTAL ACTIVITIES OF DAILY LIVING (I-ADL) IN PATIENTS WITH PRIMARY BRAIN TUMOURS: RESULTS OF PHASE 1 von Dirven, L., Meijer, W., Sikkes, S.A.M., Reijneveld, J.C., Aaronson, N.K., Uitdehaag, B.M.J., Taphoorn, M. J. B.

Volltext

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI von GEURTS, J. J. G, ROOSENDAAL, S. D, ROCCA, M. A, WATTJES, M. P, YOUSRY, T. A, UITDEHAAG, B. M. J, BARKHOF, F, CALABRESE, M, CICCARELLI, O, AGOSTA, F, CHARD, D. T, GASS, A, HUERGA, E, MORAAL, B, PARETO, D

Volltext

PP073-SUN RESTING ENERGY EXPENDITURE IN HEAD AND NECK CANCER PATIENTS DURING RADIOTHERAPY von Langius, J.A.E, Kruizenga, H.M, Uitdehaag, B.M.J, Langendijk, J.A, Doornaert, P, Leemans, C.R, Weijs, P.J.M

Volltext

Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease von Killestein, J., den Drijver, B.F., van der Graaff, W.L., Uitdehaag, B.M.J., Polman, C.H., van Lier, R.A.W.

Volltext

Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results von Nielsen, J.M., Moraal, B., Polman, C.H., Poppe, P., de Vos, M., Freedman, M.S., Kappos, L., Barkhof, F., Bauer, L., Pohl, C., Sandbrink, R., Hartung, H.-P., Uitdehaag, B.M.J.

Volltext

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire von Oort, Q., Reijneveld, J.C., Sikkes, S.A.M., Koekkoek, J.A.F., Boele, F., Young, T., Brannan, C., Chalk, T., Talacchi, A., Mazzotta, A., Narita, Y., Sato, H., Miyakita, Y., Shamieh, O., Alrjoob, W., Pace, A., Petranovic, D., Ploh, M., Capela, A., Silva, J., Hjermstad, M.J., Purkart, T. Urbanic, Seidel, C., Talhi, N., Pichler, J., Höllmüller, I., Brown, L., Hand, M., Klein, M., Aaronson, N.K., Uitdehaag, B.M.J., Taphoorn, M.J.B., Dirven, L.

Volltext

The FAS−670 polymorphism influences susceptibility to multiple sclerosis von van Veen, T, Kalkers, N.F, Crusius, J.B.A, van Winsen, L, Barkhof, F, Jongen, P.J.H, Peña, A.S, Polman, C.H, Uitdehaag, B.M.J

Volltext

Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant? von BARKHOF, F, HULST, H. E, DRULOVIC, J, UITDEHAAG, B. M. J, MATSUDA, K, LANDIN, R

Volltext

Saccadic delay in multiple sclerosis: A quantitative description von Nij Bijvank, J.A., Petzold, A., Coric, D., Tan, H.S., Uitdehaag, B.M.J., Balk, L.J., van Rijn, L.J.

Volltext

Methylprednisolone for acute relapses of multiple sclerosis: Can oral replace intravenous administration? von UITDEHAAG, B. M. J, BARKHOF, F

Volltext

POSTWITHDRAWAL REBOUND INCREASE IN T2 LESIONAL ACTIVITY IN NATALIZUMAB-TREATED MS PATIENTS von VELLINGA, M. M, CASTELIJNS, J. A, BARKHOF, F, UITDEHAAG, B. M. J, POLMAN, C. H

Volltext